Cabozantinib (Cabometyx/Cometriq)

[ ANTI-CANCER DRUGS ]
UNIT PRICE: 2,999.00 USD
  2,999.00 USD
In Stock

sold under the brand-name Cabometyx and Cometriq

Related Products

Product Details

Medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc.
VIEW ALL PRODUCTS